Identification of hub genes and potential drugs in hepatocellular carcinoma through integrated bioinformatics analysis
Authors:
Preprint
- 14 October 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
BackgroundHepatocellular carcinoma (HCC) is the third cancer-related cause of death in the world. Until now, the involved mechanisms during the development of HCC are largely unknown. This study aims to explore the driven-genes and potential drugs in HCC. MethodsThree mRNA expression datasets were used to analyze the differentially expressed genes (DEGs) in HCC. The bioinformatics approaches include identification of DEGs and hub genes, GO terms analysis and KEGG enrichment analysis, construction of protein–protein interaction network. The expression levels of hub genes were validated based on TCGA, GEPIA and the Human Protein Atlas. Moreover, overall survival and disease-free survival analysis of the hub genes were further conducted by Kaplan-Meier plotter and the GEPIA. DGIdb database was performed to search the candidate drugs for HCC. ResultsFinally, 197 DEGs were identified. The PPI network was constructed using STRING software. Then ten genes were selected and considered as the hub genes. The ten genes were all closely related to the survival of HCC patients. DGIdb database predicted 39 small molecules as the possible drugs for treating HCC. ConclusionsOur study provides some new insights into HCC pathogenesis and treatments. The candidate drugs may improve the efficiency of HCC therapy in future.Keywords
All Related Versions
This publication has 65 references indexed in Scilit:
- Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapySupportive Care in Cancer, 2018
- Gene expression analysis of biopsy samples reveals critical limitations of transcriptome‐based molecular classifications of hepatocellular carcinomaThe Journal of Pathology: Clinical Research, 2016
- FunRich: An open access standalone functional enrichment and interaction network analysis toolProteomics, 2015
- Aurora kinase A mediates c‐Myc's oncogenic effects in hepatocellular carcinomaMolecular Carcinogenesis, 2014
- Antibodies for profiling the human proteome—The Human Protein Atlas as a resource for cancer researchProteomics, 2012
- Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasisHepatology, 2012
- Deregulation of FoxM1b leads to tumour metastasisEMBO Molecular Medicine, 2010
- Overlapping High-Resolution Copy Number Alterations in Cancer Genomes Identified Putative Cancer Genes in Hepatocellular CarcinomaHepatology, 2010
- Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinomaCancer, 2005
- Overexpression of cyclin B1 in human colorectal cancersJournal of Cancer Research and Clinical Oncology, 1997